Twist Bioscience Corporation header image

Twist Bioscience Corporation

TWST

Equity

ISIN null / Valor 44023909

NASDAQ (2026-04-24)
USD 60.94+3.55%

Twist Bioscience Corporation
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Twist Bioscience Corporation is a publicly traded synthetic biology company (NASDAQ: TWST) based in San Francisco that develops and manufactures synthetic DNA and related products using a proprietary silicon-based, high-throughput oligonucleotide synthesis platform. The company supplies custom oligonucleotides, gene fragments, variant libraries and related design and library services, and offers next‑generation sequencing target enrichment kits and other consumables to customers across pharmaceuticals, biotech, diagnostics, agriculture and industrial biotechnology, supporting applications such as therapeutic discovery, assay development, genomic research and synthetic biology workflows. Its revenue mix includes product sales, services and collaborative agreements with commercial and academic partners, and it pursues adjacent opportunities—such as work on DNA-based data storage—aimed at expanding demand for large-scale, accurate DNA synthesis.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

51.7%1Y
347%3Y
-54.2%5Y

Performance

66.5%1Y
69.7%3Y
75.9%5Y

Volatility

Market cap

3736 M

Market cap (USD)

Daily traded volume (Shares)

945,352

Daily traded volume (Shares)

1 day high/low

47.845 / 45.93

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Senned Tomeh
United Kingdom, 21 Oct 2025
star star star star star
Very promising investment due to its great headroom in potential for its very fast developing innovation in its sector.

EQUITIES OF THE SAME SECTOR

Netflix Inc
Netflix Inc Netflix Inc Valor: 1413346
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 92.44
NVIDIA Corp
NVIDIA Corp NVIDIA Corp Valor: 994529
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%USD 208.27
Advanced Micro Devices Inc
Advanced Micro Devices Inc Advanced Micro Devices Inc Valor: 903491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
13.91%USD 347.81
Alphabet Inc
Alphabet Inc Alphabet Inc Valor: 29798545
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.35%USD 342.32
SK hynix Inc
SK hynix Inc SK hynix Inc Valor: 18382960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.38%EUR 744.00
Brady Corp
Brady Corp Brady Corp Valor: 913942
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.69%USD 80.70
CDW Corporation
CDW Corporation CDW Corporation Valor: 21034308
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.84%USD 135.32
Biomarin Pharmaceutical Inc
Biomarin Pharmaceutical Inc Biomarin Pharmaceutical Inc Valor: 729021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.48%USD 53.18
Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%USD 9.26
Array Technologies Inc
Array Technologies Inc Array Technologies Inc Valor: 57373259
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 8.11